Novel combretastatin A-4 derivative containing aminophosphonates as dual inhibitors of tubulin and matrix metalloproteinases for lung cancer treatment-Reference-Cited by-同舟云学术

Novel combretastatin A-4 derivative containing aminophosphonates as dual inhibitors of tubulin and matrix metalloproteinases for lung cancer treatment

Published:2022-12 Issue: Volume:244 Page:114817
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Huang Xiaochao,Chen Yuanhang,Zhong Wentian,Liu Zhikun,Zhang Haijiang,Zhang Bin,Wang Hengshan

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference71 articles.

1. Novel 3-substituted 7-phenylpyrrolo[3,2-f ]quinolin-9(6H)-ones as single entities with multitarget antiproliferative activity;Carta;J. Med. Chem.,2015

2. Discovery of a novel stilbene derivative as a microtubule targeting agent capable of inducing cell ferroptosis;Zhou;J. Med. Chem.,2022

3. Microtubules as a target for anticancer drugs;Jordan;Nat. Rev. Cancer,2004

4. On and around microtubules: an overview;Wade;Mol. Biotechnol.,2009

5. Discovery of novel benzimidazole and indazole analogues as tubulin polymerization inhibitors with potent anticancer activities;Ren;J. Med. Chem.,2021

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytotoxic Activity of Distinct Families of Phosphonic Acid Derivatives – A Chemocentric Approach to Assess Their Molecular Action;ChemMedChem;2024-08-23

2. Novel tubulin polymerization inhibitors based on the hybridization of coumarin and indole ring: Design, synthesis and bioactivities evaluation;Journal of Molecular Structure;2024-06

3. Natural Products as Regulators against Matrix Metalloproteinases for the Treatment of Cancer;Biomedicines;2024-04-03

4. Design, Synthesis, Molecular Docking and Cytotoxicity of Stilbene-arylcinnamide Hybrids on A549 Lung Cancer Cells;Current Organic Chemistry;2023-08

5. Hybridization of the Pharmacophoric Features of Discoipyrrole C and Combretastatin A‐4 toward New Anticancer Leads;ChemMedChem;2023-06-27